Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
From CNBC.com News
This water treatment startup is already a unicorn, and has $225 million in VC funding
August 27, 2024
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Friday
August 23, 2024
From CNBC.com News
CNBC Daily Open: Stocks slide ahead of Powell speech
August 22, 2024
From CNBC.com News
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
August 22, 2024
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
From CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
August 14, 2024
From CNBC.com News
Top Wall Street analysts are bullish on these dividend stocks
August 11, 2024
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
From CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test
July 18, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Rural retailer Tractor Supply eliminates DEI roles, Pride support and carbon emissions goals
June 28, 2024
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
From CNBC.com News
From CNBC.com News
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
June 10, 2024
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
From CNBC.com News
Here's how U.S. health officials are responding to bird flu in humans after second case
May 24, 2024
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.